Jun-Hang Luo
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- Renal cell carcinoma treatment 33
- Ferroptosis and cancer prognosis 7
- Prostate Cancer Treatment and Research 6
- Oncology 23
- Cancer Immunotherapy and Biomarkers 17
- Co-authors
- Dan Xie (16 shared papers)Jinhuan Wei (28 shared papers)Jiaxing Zhang (9 shared papers)Junjie Cen (22 shared papers)Haohua Yao (14 shared papers)Yong Fang (17 shared papers)Jun Kun Lu (22 shared papers)Lei Tan (9 shared papers)
- Journals
- Oncogene (5 papers)癌症:英文版 (4 papers)Cancer Letters (4 papers)Molecular Cancer (4 papers)Cancer Medicine (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Jun-Hang Luo
122 papers receiving 4.6k citations
Jun-Hang Luo's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 755
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 770
- Oncology 534
- Hepatology 115
Countries citing papers authored by Jun-Hang Luo
This map shows the geographic impact of Jun-Hang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun-Hang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun-Hang Luo more than expected).
Fields of papers citing papers by Jun-Hang Luo
This network shows the impact of papers produced by Jun-Hang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun-Hang Luo. The network helps show where Jun-Hang Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun-Hang Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs Hit paper breakdown → | 2019 | 635 |
| 2 | 2013 | 477 | |
| 3 | 2018 | 296 | |
| 4 | 2019 | 167 | |
| 5 | 2021 | 152 | |
| 6 | 2017 | 133 | |
| 7 | 2004 | 108 | |
| 8 | 2015 | 107 | |
| 9 | 2021 | 87 | |
| 10 | 2019 | 81 | |
| 11 | 2008 | 75 | |
| 12 | 2019 | 73 | |
| 13 | 2018 | 70 | |
| 14 | 2022 | 70 | |
| 15 | 2013 | 57 | |
| 16 | 2018 | 57 | |
| 17 | 2012 | 55 | |
| 18 | 2022 | 55 | |
| 19 | 2017 | 54 | |
| 20 | 2015 | 52 |
About Jun-Hang Luo
Jun-Hang Luo is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 126 papers that have together received 4.6k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (33 papers), Cancer Immunotherapy and Biomarkers (17 papers), Bladder and Urothelial Cancer Treatments (16 papers), Circular RNAs in diseases (11 papers), RNA modifications and cancer (8 papers), Ferroptosis and cancer prognosis (7 papers), Cancer-related molecular mechanisms research (6 papers) and Prostate Cancer Treatment and Research (6 papers). The work is most often cited by research in Cancer Research (755 citations), Molecular Biology (1.9k citations), Pulmonary and Respiratory Medicine (770 citations), Oncology (534 citations) and Hepatology (115 citations). Jun-Hang Luo has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Dan Xie, Jinhuan Wei, Jiaxing Zhang, Junjie Cen, Haohua Yao, Yong Fang, Jun Kun Lu, Lei Tan, Yi-Ji Liao and Bing Liao. Their work appears in journals such as Oncogene, 癌症:英文版, Cancer Letters, Molecular Cancer and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.